Insertion of an incomplete Doc element in the third exon.
Mitosis 15 is slightly abnormal in Spc105R1 embryos; lagging centromeres are often seen but the duration of mitosis 15 appears normal.
Homozygous embryos derived from heterozygous parents show defects during mitosis 16. Some cells undergo a prolonged metaphase before entering an abnormal anaphase. The remaining cells remain in prometaphase for the analysed time period (14 minutes), are unable to align their chromosomes into a metaphase plate and do not enter anaphase. More than 90% of anaphase/telophase figures are abnormal. Lagging chromosomes are seen and centromeres are rarely clustered (in contrast to wild type), and more severe defects are also seen.
Spc105R1 embryos still have spindle assembly checkpoint function at the mitosis 16 stage (assayed by their response to colchicine treatment).
More than 90% of anaphase/telophase figures are abnormal in mitosis 16 of Spc105R1/Df(3L)ri-XT1 and Spc105R1/Spc105RP01511LE embryos.
Spc105R1 has lethal | recessive phenotype, suppressible by Spc105R::Dwil\Spc105Rwr15
Spc105R1 has lethal | recessive phenotype, suppressible by Spc105R::Dwil\Spc105Rwr30
Spc105R[+]/Spc105R1 is an enhancer of visible phenotype of thrΔC.GMR.Tag:MYC
Spc105R[+]/Spc105R1 is an enhancer of eye phenotype of thrΔC.GMR.Tag:MYC
Spc105R::Dwil\Spc105Rwr15 and Spc105R::Dwil\Spc105Rwr30 each promote the development of Spc105R1 hemizygotes to fertile adults.
Spc105R1 is rescued by Spc105R+tg
Spc105R1 is rescued by Spc105RC.EGFP
Spc105R1 is rescued by Spc105Rwr1
Spc105R1 is partially rescued by Spc105RC.UAS.EGFP/Scer\GAL4VP16.mat.αTub67C
Spc105RP01511LE/Spc105R1 is partially rescued by Spc105Rwr1
Spc105R1 is not rescued by Scer\GAL4VP16.mat.αTub67C/Spc105RN.UAS.EGFP
Spc105R1 is not rescued by Spc105RM.UAS.EGFP/Scer\GAL4VP16.mat.αTub67C
Spc105R+tg rescues both the recessive lethality and the dominant enhancement of the thrΔC.GMR.T:Hsap\MYC eye phenotype which is seen in Spc105R1 mutants.
Spc105Rwr1 promotes the development of Spc105R1 hemizygotes to fertile adults and almost completely rescues the abnormal anaphase/telophase figures seen during mitosis 16 in Spc105R1/Spc105RP01511LE embryos.
Expression of Spc105RFL.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16 rescues the mitotic defects seen in Spc105R1 embryos at mitosis 16.
Expression of either Spc105RM.Scer\UAS.T:Avic\GFP-EGFP or Spc105RN.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16 does not rescue the mitotic defects seen in Spc105R1 embryos at mitosis 16.
Expression of Spc105RC.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4mat.αTub67C.T:Hsim\VP16 almost completely rescues the mitotic defects seen in Spc105R1 embryos at mitosis 16.
Spc105RgC cannot rescue the lethality of Spc105R1 homozygotes.
Separable from: Df(3R)Exel9014.
The Spc105R1 mutation is a second site mutation that was originally discovered on the Df(3R)Exel9014 chromosome.